ERBB2 and breast cancer: After a median follow‐up of 83 months, a total of 444 and 289 deaths were documented in HER2‐low and HER2‐zero BC, with crude mortality rates of 11.68 and 9.49 per 1000 person‐years, respectively (Table S2).